Oncology bears a particular potential for translating research findings from the laboratory into clinical applications. Innovative strategies are urgently needed in the areas of diagnosis, patient risk stratification and treatment. The focus of the Division is to develop translational research programmes and clinical research. The tenet of the Division’s plans is that any significant progress toward the cure of cancer can only be based on an improved understanding of its pathogenesis, which, in turn, will lead to the development of improved diagnostics and more rationale therapeutic interventions.
The division is organized into 11 basic research units and 22 clinical research units with a total number of over 130 scientists including clinician-scientists. It comprises the Urological Research Institute (URI). View all the research units here.
Extensive collaborations and joint activities will accelerate the implementation of translational research through access to a large number of patients and samples and combined resource platforms.
The division is joining efforts with the Clinical Departments of Onco-hematology and Oncology to create a virtual cancer center with a network organization, multidisciplinary teams and defined programs for different tumors and takes advantage of the collaborative use of resources, platforms and infrastructures with other Research Divisions and facilities.
- Cancer Genetics;
- Cancer Microenvironment;
- Cancer Immunology and Immunotherapy.
Group leader, Preclinical models of cancer Unit
Paolo Giorgio Arcidiacono
Clinical grouop leader, Biliopancreatic endoscopy and endoscopic ultrasonography Unit
Clinical group leader, Clinical onco-hematology Unit
Group leader, Lymphoid organ development and function Unit
Head, Tumor biology and vascular targeting Unit
Head, Pancreas translational and clinical Unit
Group leader, Biology of multiple myeloma Unit
Andrés José María Ferreri
Head, Lymphoma Unit
Group leader, Tumor microenvironment Unit
Head, B-cell neoplasia Unit
Clinical group leader, Gynecologic oncology Unit
Group leader, Cell signaling Unit
Head, Gastrointestinal surgery Unit
Head, Immuno-biotherapy of melanoma and solid tumors Unit
Head, Functional genomics of cancer Unit
Biliopancreatic endoscopy and endoscopic ultrasonography
Paolo Giorgio Arcidiacono
Biology of Multiple Myeloma
Functional genomics of cancer
Immuno-biotherapy of melanoma and solid tumors
Lymphoid organ development and function
Andrés José Marìa Ferreri
Pancreas translational and clinical Unit
Preclinical models of cancer
Tumor biology and vascular targeting